YAP1 and pancreatic neoplasm: By excluding patients undergoing chemotherapy or radiation, the data showed that the YAP1 expression influences overall survival only in pancreatic cancer (MST: 278 vs. 684 days, P < 0.0001) (Figure 7(a)).